Back to Search Start Over

PREPARE trial: a protocol for a multicentre randomised trial of frailty-focused preoperative exercise to decrease postoperative complication rates and disability scores

Authors :
Dean A Fergusson
Alan Forster
Gregg Nelson
Monica Taljaard
Jayna Holroyd-Leduc
Manoj M Lalu
John Muscedere
Duminda Wijeysundera
Daniel I McIsaac
Sylvain Boet
Kednapa Thavorn
Michael McMullen
Tarit Saha
Eric Jacobsohn
Tien Le
Husein Moloo
Allen Huang
Gary Dobson
Grace Ma
Stephanie Johnson
Colin McCartney
Elijah Dixon
Emily Hladkowicz
Sylvain Gagne
Julie Nantel
Barbara Power
Chelsia Gillis
Rodney Breau
Irfan Dhalla
Susan Lee
Rachel Khadaroo
Amanda Meliambro
Daniel Trottier
Keely Barnes
Laura Boland
Karina Branje
Gregory L. Bryson
Rosaleen Chun
Antoine Eskander
Hannah Frazer
Joanne Hutton
John Joanisse
Ana Johnson
Luke T. Lavallee
Cameron Love
Ronald Moore
Thomas Mutter
Sudhir Nagpal
Celena Scheede-Bergdhal
Pablo Serrano
Laura Tamblyn-Watts
Carl van Walraven
Brittany Warren
Ilun Yang
Source :
BMJ Open, Vol 12, Iss 8 (2022)
Publication Year :
2022
Publisher :
BMJ Publishing Group, 2022.

Abstract

Introduction Frailty is a strong predictor of adverse postoperative outcomes. Prehabilitation may improve outcomes after surgery for older people with frailty by addressing physical and physiologic deficits. The objective of this trial is to evaluate the efficacy of home-based multimodal prehabilitation in decreasing patient-reported disability and postoperative complications in older people with frailty having major surgery.Methods and analysis We will conduct a multicentre, randomised controlled trial of home-based prehabilitation versus standard care among consenting patients >60 years with frailty (Clinical Frailty Scale>4) having elective inpatient major non-cardiac, non-neurologic or non-orthopaedic surgery. Patients will be partially blinded; clinicians and outcome assessors will be fully blinded. The intervention consists of >3 weeks of prehabilitation (exercise (strength, aerobic and stretching) and nutrition (advice and protein supplementation)). The study has two primary outcomes: in-hospital complications and patient-reported disability 30 days after surgery. Secondary outcomes include survival, lower limb function, quality of life and resource utilisation. A sample size of 750 participants (375 per arm) provides >90% power to detect a minimally important absolute difference of 8 on the 100-point patient-reported disability scale and a 25% relative risk reduction in complications, using a two-sided alpha value of 0.025 to account for the two primary outcomes. Analyses will follow intention to treat principles for all randomised participants. All participants will be followed to either death or up to 1 year.Ethics and dissemination Ethical approval has been granted by Clinical Trials Ontario (Project ID: 1785) and our ethics review board (Protocol Approval #20190409-01T). Results will be disseminated through presentation at scientific conferences, through peer-reviewed publication, stakeholder organisations and engagement of social and traditional media.Trial registration number NCT04221295.

Subjects

Subjects :
Medicine

Details

Language :
English
ISSN :
20446055
Volume :
12
Issue :
8
Database :
Directory of Open Access Journals
Journal :
BMJ Open
Publication Type :
Academic Journal
Accession number :
edsdoj.6d39c9b5aa754cb5a45f01e9fd67d633
Document Type :
article
Full Text :
https://doi.org/10.1136/bmjopen-2022-064165